VGAT activators constitute a diverse group of chemicals that indirectly promote the function of VGAT. These activators typically exert their influence through various signaling pathways and cellular processes that, in turn, affect VGAT's role in neurotransmitter transport into synaptic vesicles. The primary effect of these activators is to enhance the efficiency and capacity of VGAT in loading neurotransmitters such as GABA and glycine into vesicles, crucial for effective synaptic transmission. Chemicals like Forskolin and Rolipram, which elevate intracellular cAMP levels, indirectly augment VGAT activity. The increase in cAMP stimulates phosphorylation processes that are likely to enhance the operational efficiency of VGAT, leading to improved neurotransmitter encapsulation and transport. Similarly, agents such as Isoproterenol, acting as a β-adrenergic agonist, and Guanfacine and Clonidine, as α2 adrenergic agonists, modulate adrenergic signaling pathways. These pathways play a significant role in neuronal excitability and neurotransmitter dynamics, indirectly impacting VGAT's function in response to altered synaptic demands.
Calcium, being a pivotal element in neurotransmitter release, is targeted by compounds like Bay K 8644, which agonizes L-type calcium channels. This action facilitates an increase in calcium influx, augmenting VGAT activity by boosting the vesicular filling process. Conversely, antagonists of inhibitory neurotransmitter receptors, such as Picrotoxin (GABA-A receptor antagonist) and Strychnine (glycine receptor antagonist), indirectly stimulate VGAT function. By reducing inhibitory signaling, these compounds create a demand for increased GABA or glycine in synaptic vesicles, possibly leading to an upregulation of VGAT to meet this need. Other compounds, like Caffeine and Nicotine, influence VGAT indirectly through their effects on overall neuronal excitability and neurotransmitter release patterns. Caffeine, by antagonizing adenosine receptors, and Nicotine, by stimulating nicotinic acetylcholine receptors, enhance synaptic activity. This increase in neuronal firing and synaptic turnover may necessitate a corresponding upregulation in VGAT activity to efficiently transport neurotransmitters into vesicles.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased cAMP levels. Elevated cAMP can enhance VGAT activity by promoting phosphorylation processes that may facilitate vesicle filling and neurotransmitter transport efficiency. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram, a selective phosphodiesterase-4 inhibitor, elevates cAMP levels by preventing its breakdown. This elevation in cAMP can indirectly enhance VGAT activity through similar mechanisms as Forskolin, potentially improving vesicular neurotransmitter uptake. | ||||||
Guanfacine | 29110-47-2 | sc-353618 | 200 mg | $1900.00 | ||
Guanfacine, an α2 adrenergic agonist, can indirectly influence VGAT activity by modulating noradrenergic signaling, which may affect neuronal excitability and neurotransmitter release dynamics, potentially enhancing VGAT's neurotransmitter loading capacity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a β-adrenergic agonist, increases cAMP levels. This elevation can indirectly impact VGAT by promoting processes that enhance neurotransmitter packaging and transport within synaptic vesicles. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Bay K 8644 is a calcium channel agonist, specifically targeting L-type calcium channels. By enhancing calcium influx, it can indirectly augment VGAT activity, as calcium is a key regulator of neurotransmitter release and vesicular loading. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine, by antagonizing adenosine receptors, leads to increased neuronal excitability. This can indirectly enhance VGAT activity by increasing the demand for neurotransmitter release and vesicular turnover. | ||||||
Picrotoxin | 124-87-8 | sc-202765 sc-202765A sc-202765B | 1 g 5 g 25 g | $67.00 $286.00 $1326.00 | 11 | |
Picrotoxin, a GABA-A receptor antagonist, indirectly enhances VGAT activity by increasing the need for GABA in synaptic vesicles due to reduced inhibitory signaling, potentially upregulating VGAT function to meet this demand. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Carbonate, while primarily known for modulating mood, can indirectly affect VGAT activity by influencing neurotransmitter release and uptake dynamics, possibly enhancing the efficiency of VGAT-mediated transport under certain conditions. | ||||||
Clonidine | 4205-90-7 | sc-501519 | 100 mg | $240.00 | 1 | |
Clonidine, an α2 adrenergic agonist like Guanfacine, can modulate VGAT activity indirectly by influencing noradrenergic signaling pathways, which can affect neuronal excitability and neurotransmitter dynamics, potentially enhancing VGAT function. | ||||||